Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Conference News TCT 2017

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Yael L. Maxwell

November 10, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

Presentation TCT 2017

Hemolysis After TMVR

Presenter: Alfredo Trento, David W.M. Muller

November 01, 2017

Presentation TCT 2017

Transseptal TMVR In MAC in a Patient With Septal Hypertrophy: Role of Pre-emptive Alcohol Septal Ablation

Presenter: Alfredo Trento, Mayra Guerrero

November 01, 2017

Presentation TCT 2017

Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Presenter: Daniel Burkhoff, Samir R. Kapadia, Toby Rogers

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Case Presentation: Valve Thrombosis After TMVR

Presenter: Vinayak Bapat, Maurice Buchbinder, Fabien Praz

October 31, 2017

Presentation TCT 2017

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

Presenter: Vinayak Bapat, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

LV Perforation After Transcatheter Mitral Valve Procedures: Frequency, Treatment Options, and Outcomes

Presenter: Vinayak Bapat, Maurice Buchbinder, Anita Asgar

October 31, 2017

Presentation TCT 2017

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Carlos E. Ruiz

October 31, 2017

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Iatrogenic ASD After Transseptal Procedures: How to Assess, When to Close

Presenter: Vinayak Bapat, Maurice Buchbinder, Christian Spies

October 31, 2017

Presentation TCT 2017

Case Presentation: TMVR With Transapical Complications

Presenter: Vinayak Bapat, Maurice Buchbinder, Vinod H. Thourani

October 31, 2017

Presentation TCT 2017

Transapical Access Update: Complications, Impact On LV Function, and Emerging Closure Devices

Presenter: Vinayak Bapat, Maurice Buchbinder, Hendrik Treede

October 31, 2017

Presentation TCT 2017

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Neil E. Moat

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Francesco Maisano

October 31, 2017

Presentation TCT 2017

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, David Meerkin

October 31, 2017

Presentation TCT 2017

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Philippe Genereux

October 31, 2017

Advertisement

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Early Pilot Study Results Show Symptom Improvement With TMVR

Hemolysis After TMVR

Transseptal TMVR In MAC in a Patient With Septal Hypertrophy: Role of Pre-emptive Alcohol Septal Ablation

Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Live From Denver: TCT 2017, Day Three

Case Presentation: Valve Thrombosis After TMVR

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

LV Perforation After Transcatheter Mitral Valve Procedures: Frequency, Treatment Options, and Outcomes

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Iatrogenic ASD After Transseptal Procedures: How to Assess, When to Close

Case Presentation: TMVR With Transapical Complications

Transapical Access Update: Complications, Impact On LV Function, and Emerging Closure Devices

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content